Thermo Fisher Scientific (TMO) Change in Acquisitions & Divestments (2009 - 2026)

Thermo Fisher Scientific has disclosed Change in Acquisitions & Divestments across 10 years of filings, most recently posting $250.0 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 12400.0% year-over-year to $250.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 billion (up 87.96% YoY) and the FY2025 annual result came in at $1.6 billion, down 11.58% from the prior year.
• Change in Acquisitions & Divestments eased to $250.0 million in Q1 2026, from $1.3 billion in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $1.8 billion in Q4 2024 and troughed at $2.0 million in Q1 2025.
• A 3-year average of $831.0 million and a median of $780.5 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments dropped 25.55% — and 2026, when it surged 12400.0%.
• Tracing TMO's Change in Acquisitions & Divestments over 3 years: stood at $1.8 billion in 2024, then slipped by 25.55% to $1.3 billion in 2025, then slumped by 80.93% to $250.0 million in 2026.
• Business Quant data shows TMO's Change in Acquisitions & Divestments at $250.0 million in Q1 2026, $1.3 billion in Q4 2025, and $2.0 million in Q1 2025.